Table 2.

Dosages of Drugs in Included Trials

Study	Beta‐blocker	Dosages	Post‐ CABG AF in prophylactic arm
Imren et al.	MPL	50 mg daily	8.8%
Lucio et al.	MPL	100–300 mg daily (titrated)	11%
Wenke et al.	MPL	1 mg/kg	4%
Paull et al.	MPL	50–200 mg daily (titrated)	24%
Yazicioglu et al.	ATL	50 mg daily	15.4%
Bert et al.	PPL	40 (10 q6h) mg daily	18%
Connolly et al.	MPL	100–150 mg daily	31%
Babin‐Ebell et al.	PPL	40 (10 q6h) mg daily	7%
Gun et al.	PPL	NK	13.2%
Ali et al.	NS	NK	17%

NS = nonspecific; NK = not known.